| Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial T Cascone, WN William Jr, A Weissferdt, CH Leung, HY Lin, A Pataer, ... Nature medicine 27 (3), 504-514, 2021 | 472 | 2021 |
| Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC): Clinical and correlative results from the NEOSTAR study. T Cascone, WN William, A Weissferdt, HY Lin, CH Leung, BW Carter, ... Journal of Clinical Oncology 37 (15_suppl), 8504-8504, 2019 | 205 | 2019 |
| Immuno-genomic landscape of osteosarcoma CC Wu, HC Beird, J Andrew Livingston, S Advani, A Mitra, S Cao, ... Nature communications 11 (1), 1008, 2020 | 173 | 2020 |
| Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial T Cascone, CH Leung, A Weissferdt, A Pataer, BW Carter, MCB Godoy, ... Nature medicine 29 (3), 593-604, 2023 | 82 | 2023 |
| Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer T Cascone, A Weissferdt, MCB Godoy, WN William Jr, CH Leung, HY Lin, ... Nature communications 12 (1), 5045, 2021 | 62 | 2021 |
| Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer B Sepesi, N Zhou, WN William Jr, HY Lin, CH Leung, A Weissferdt, ... The Journal of Thoracic and Cardiovascular Surgery 164 (5), 1327-1337, 2022 | 48 | 2022 |
| Clinical activity of pazopanib in patients with advanced desmoplastic small round cell tumor BA Menegaz, B Cuglievan, J Benson, P Camacho, ... The oncologist 23 (3), 360-366, 2018 | 47 | 2018 |
| Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma R Rathore, KE Caldwell, C Schutt, CB Brashears, BC Prudner, ... Cell reports 34 (4), 2021 | 44 | 2021 |
| Risk factors for falls in older patients with cancer X Zhang, M Sun, S Liu, CH Leung, L Pang, UR Popat, R Champlin, ... BMJ supportive & palliative care 8 (1), 34-37, 2018 | 37 | 2018 |
| Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer-NEOSTAR Study B Sepesi, T Cascone, W William, H Lin, C Leung, A Weissferdt, G Walsh, ... Journal of Thoracic Oncology 14 (10), S241-S242, 2019 | 32 | 2019 |
| Clinicopathological analysis of ATRX, DAXX and NOTCH receptor expression in angiosarcomas G Panse, JSA Chrisinger, CH Leung, DR Ingram, S Khan, K Wani, H Lin, ... Histopathology 72 (2), 239-247, 2018 | 24 | 2018 |
| Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC) T Cascone, WN William, A Weissferdt, CH Leung, L Federico, ... Annals of Oncology 29, viii738, 2018 | 23 | 2018 |
| The degree of sclerosis is associated with prognosis in well‐differentiated liposarcoma of the retroperitoneum JSA Chrisinger, T Al‐Zaid, EZ Keung, C Leung, HY Lin, CL Roland, ... Journal of surgical oncology 120 (3), 382-388, 2019 | 16 | 2019 |
| Qt prolongation in cancer patients P Kim, L Masha, A Olson, C Iliescu, K Karimzad, S Hassan, N Palaskas, ... Frontiers in Cardiovascular Medicine 8, 45, 2021 | 15 | 2021 |
| Outcomes of systemic therapy in metastatic phyllodes tumor of the breast A Parkes, WL Wang, S Patel, CH Leung, H Lin, AP Conley, N Somaiah, ... Breast Cancer Research and Treatment 186, 871-882, 2021 | 14 | 2021 |
| Nodal Immune Flare (NIF) Following Neoadjuvant Anti-PD-1 and Anti-CTLA-4 Therapy in Non-Small Cell Lung Cancer B Sepesi, M Godoy, W William, A Vaporciyan, H Lin, C Leung, J Lee, ... Journal of Thoracic Oncology 14 (10), S745, 2019 | 14 | 2019 |
| Fracture risk prediction using FRAX in patients following hematopoietic stem cell transplantation X Pundole, WA Murphy, CC Ebede, E Karim, S Manocha, D Don-Pedro, ... Archives of Osteoporosis 13, 1-8, 2018 | 14 | 2018 |
| Analysis of HSP27 and the autophagy marker LC3B+ Puncta following preoperative chemotherapy identifies high-risk osteosarcoma patients JA Livingston, WL Wang, JW Tsai, AJ Lazar, CH Leung, H Lin, S Advani, ... Molecular cancer therapeutics 17 (6), 1315-1323, 2018 | 14 | 2018 |
| The immune landscape of undifferentiated pleomorphic sarcoma R Lazcano, CM Barreto, R Salazar, F Carapeto, RS Traweek, CH Leung, ... Frontiers in Oncology 12, 1008484, 2022 | 13 | 2022 |
| Breast and lung effusion survival score models: improving survival prediction in patients with malignant pleural effusion and metastasis S Molina, G Martinez-Zayas, PV Sainz, CH Leung, L Li, HB Grosu, ... Chest 160 (3), 1075-1094, 2021 | 13 | 2021 |
